CMap Candidates
CMap (Connectivity Map) candidates are extracted from CLUE (CMap and LINCS Unified Environment), with detailed information, e.g., perturbagen time and dose, compound structure, targets, SMILES, mechanism of action. Two publicly available gene expression profiles of NAFLD are used to calculate individual connectivity scores and corresponding statistical significances for these candidates.
stats1
stats2
34330 records.
| CMap ID | Pert ID | Compound Name | Targets | MoA | Compound Aliases | |
|---|---|---|---|---|---|---|
| C13904 | BRD-K36217065 | BRD-K36217065 | -- | -- | -- | Details |
| C13905 | BRD-K36221157 | BRD-K36221157 | -- | -- | -- | Details |
| C13906 | BRD-K36226647 | BRD-K36226647 | -- | -- | -- | Details |
| C13907 | BRD-K36228696 | BRD-K36228696 | -- | -- | -- | Details |
| C13908 | BRD-K36232701 | BRD-K36232701 | -- | -- | -- | Details |
| C13909 | BRD-K36232729 | BRD-K36232729 | -- | -- | -- | Details |
| C13910 | BRD-K36232819 | BRD-K36232819 | -- | -- | -- | Details |
| C13911 | BRD-K36234266 | carmustine | GSR | DNA inhibitor; DNA alkylating agent | -- | Details |
| C13912 | BRD-K36237864 | BRD-K36237864 | -- | -- | -- | Details |
| C13913 | BRD-K36241360 | BRD-K36241360 | -- | -- | -- | Details |
| C13914 | BRD-K36248164 | etretinate | RARA; RXRG | Protein synthesis inhibitor | -- | Details |
| C13915 | BRD-K36250651 | BRD-K36250651 | -- | -- | -- | Details |
| C13916 | BRD-K36252987 | BRD-K36252987 | -- | -- | -- | Details |
| C13917 | BRD-K36258877 | AZ-10417808 | CASP3 | Caspase inhibitor | -- | Details |
| C13918 | BRD-K36261261 | BRD-K36261261 | -- | -- | -- | Details |
| C13919 | BRD-K36264978 | KM-03439 | -- | -- | -- | Details |
| C13920 | BRD-K36267058 | BAS-02859604 | -- | -- | -- | Details |
| C13921 | BRD-K36269259 | BRD-K36269259 | -- | -- | -- | Details |
| C13922 | BRD-K36269323 | asymmetrical-dimethylarginine | NOS2; NOS3 | Nitric oxide synthase inhibitor; Dimethylarginine dimethylaminohydrolase inhibitor | -- | Details |
| C13923 | BRD-K36270037 | esculin | -- | -- | -- | Details |
| C13924 | BRD-K36271521 | BRD-K36271521 | -- | -- | -- | Details |
| C13925 | BRD-K36276950 | BRD-K36276950 | -- | -- | -- | Details |
| C13926 | BRD-K36278687 | BRD-K36278687 | -- | -- | -- | Details |
| C13927 | BRD-K36280065 | tofacitinib | JAK1; JAK2; JAK3 | JAK inhibitor | -- | Details |
| C13928 | BRD-K36282114 | BRD-K36282114 | -- | -- | -- | Details |
| C13929 | BRD-K36284700 | BRD-K36284700 | -- | -- | -- | Details |
| C13930 | BRD-K36287933 | BRD-K36287933 | -- | -- | -- | Details |
| C13931 | BRD-K36289461 | BRD-K36289461 | -- | -- | -- | Details |
| C13932 | BRD-K36289669 | BRD-K36289669 | -- | -- | -- | Details |
| C13933 | BRD-K36289678 | BRD-K36289678 | -- | -- | -- | Details |
| C13934 | BRD-K36290066 | BRD-K36290066 | -- | -- | -- | Details |
| C13935 | BRD-K36296949 | BRD-K36296949 | -- | -- | -- | Details |
| C13936 | BRD-K36298208 | BRD-K36298208 | -- | -- | -- | Details |
| C13937 | BRD-K36313546 | BRD-K36313546 | -- | -- | -- | Details |
| C13938 | BRD-K36314330 | BRD-K36314330 | -- | -- | -- | Details |
| C13939 | BRD-K36314834 | BRD-K36314834 | -- | -- | 1-[2-(2,3-Dihydro-benzo[1,4]dioxin-6-yl)-2-oxo-ethyl]-4-((E)-styryl)-pyridinium | Details |
| C13940 | BRD-K36317223 | BRD-K36317223 | -- | -- | -- | Details |
| C13941 | BRD-K36320220 | BRD-K36320220 | -- | -- | -- | Details |
| C13942 | BRD-K36324071 | NF-449 | P2RX1 | Purinergic receptor antagonist | -- | Details |
| C13943 | BRD-K36324810 | BRD-K36324810 | -- | -- | -- | Details |
| C13944 | BRD-K36333904 | BRD-K36333904 | -- | -- | -- | Details |
| C13945 | BRD-K36337571 | BRD-K36337571 | -- | -- | -- | Details |
| C13946 | BRD-K36340167 | BRD-K36340167 | -- | -- | -- | Details |
| C13947 | BRD-K36347292 | BRD-K36347292 | -- | -- | -- | Details |
| C13948 | BRD-K36352298 | BRD-K36352298 | -- | -- | -- | Details |
| C13949 | BRD-K36353158 | BRD-K36353158 | -- | -- | -- | Details |
| C13950 | BRD-K36354764 | BRD-K36354764 | -- | -- | -- | Details |
| C13951 | BRD-K36360168 | BRD-K36360168 | -- | -- | -- | Details |
| C13952 | BRD-K36363294 | I-BET-151 | -- | -- | GSK-1210151A | Details |
| C13953 | BRD-K36365616 | BRD-K36365616 | -- | -- | -- | Details |
| C13954 | BRD-K36368568 | BRD-K36368568 | -- | -- | -- | Details |
| C13955 | BRD-K36376229 | BRD-K36376229 | -- | -- | -- | Details |
| C13956 | BRD-K36377456 | marmesin | -- | -- | -- | Details |
| C13957 | BRD-K36379990 | riodipine | -- | -- | -- | Details |
| C13958 | BRD-K36381762 | BRD-K36381762 | -- | -- | nor-binaltorphimine-dihydrochloride | Details |
| C13959 | BRD-K36382446 | BRD-K36382446 | -- | -- | -- | Details |
| C13960 | BRD-K36386086 | dolutegravir | CYP3A7; CYP3A4; CYP3A5; POU2F2; UGT1A1 | HIV integrase inhibitor | -- | Details |
| C13961 | BRD-K36393312 | BRD-K36393312 | -- | -- | -- | Details |
| C13962 | BRD-K36394966 | BRD-K36394966 | -- | -- | -- | Details |
| C13963 | BRD-K36395411 | SB-206553 | HTR2B; HTR2C | Serotonin receptor antagonist | -- | Details |
| C13964 | BRD-K36397874 | BRD-K36397874 | -- | -- | -- | Details |
| C13965 | BRD-K36415399 | BRD-K36415399 | -- | -- | -- | Details |
| C13966 | BRD-K36418235 | BRD-K36418235 | -- | -- | -- | Details |
| C13967 | BRD-K36422663 | BRD-K36422663 | -- | -- | -- | Details |
| C13968 | BRD-K36424197 | BRD-K36424197 | -- | -- | -- | Details |
| C13969 | BRD-K36424250 | BRD-K36424250 | -- | -- | -- | Details |
| C13970 | BRD-K36439830 | BRD-K36439830 | -- | -- | -- | Details |
| C13971 | BRD-K36445086 | BRD-K36445086 | -- | -- | -- | Details |
| C13972 | BRD-K36446300 | BRD-K36446300 | -- | -- | -- | Details |
| C13973 | BRD-K36446940 | BRD-K36446940 | -- | -- | -- | Details |
| C13974 | BRD-K36451640 | BRD-K36451640 | -- | -- | -- | Details |
| C13975 | BRD-K36452089 | tert-butylhydroquinone | -- | -- | -- | Details |
| C13976 | BRD-K36460068 | BRD-K36460068 | -- | -- | -- | Details |
| C13977 | BRD-K36460699 | BRD-K36460699 | -- | -- | -- | Details |
| C13978 | BRD-K36462169 | BRD-K36462169 | -- | -- | -- | Details |
| C13979 | BRD-K36464765 | BRD-K36464765 | -- | -- | -- | Details |
| C13980 | BRD-K36465335 | BRD-K36465335 | -- | -- | -- | Details |
| C13981 | BRD-K36466190 | BRD-K36466190 | -- | -- | -- | Details |
| C13982 | BRD-K36467523 | bindarit | CCL2; CCL7; CCL8 | NFKB pathway inhibitor | -- | Details |
| C13983 | BRD-K36467636 | BRD-K36467636 | -- | -- | -- | Details |
| C13984 | BRD-K36468214 | BRD-K36468214 | -- | -- | -- | Details |
| C13985 | BRD-K36471847 | BRD-K36471847 | -- | -- | -- | Details |
| C13986 | BRD-K36473494 | BRD-K36473494 | -- | -- | -- | Details |
| C13987 | BRD-K36474885 | BRD-K36474885 | -- | -- | -- | Details |
| C13988 | BRD-K36489877 | BRD-K36489877 | -- | -- | -- | Details |
| C13989 | BRD-K36490574 | BRD-K36490574 | -- | -- | -- | Details |
| C13990 | BRD-K36493118 | BRD-K36493118 | -- | -- | -- | Details |
| C13991 | BRD-K36512157 | BRD-K36512157 | -- | -- | -- | Details |
| C13992 | BRD-K36513323 | BRD-K36513323 | -- | -- | -- | Details |
| C13993 | BRD-K36515664 | BRD-K36515664 | -- | -- | -- | Details |
| C13994 | BRD-K36516410 | BRD-K36516410 | -- | -- | -- | Details |
| C13995 | BRD-K36517203 | BRD-K36517203 | -- | -- | -- | Details |
| C13996 | BRD-K36523261 | BRD-K36523261 | -- | -- | -- | Details |
| C13997 | BRD-K36529613 | PU-H71 | HSP90AA1 | HSP inhibitor | -- | Details |
| C13998 | BRD-K36531580 | BRD-K36531580 | -- | -- | -- | Details |
| C13999 | BRD-K36533576 | KU-C103875 | -- | -- | -- | Details |
| C14000 | BRD-K36537572 | BRD-K36537572 | -- | -- | -- | Details |
| C14001 | BRD-K36539857 | BRD-K36539857 | -- | -- | -- | Details |
| C14002 | BRD-K36544054 | BRD-K36544054 | -- | -- | -- | Details |
| C14003 | BRD-K36553386 | BRD-K36553386 | -- | -- | -- | Details |